Stockscreener 앱 받기
5.83
4.29%
0.24
전일 마감가:
$5.59
열려 있는:
$5.62
하루 거래량:
1.25M
Relative Volume:
1.15
시가총액:
$310.35M
수익:
-
순이익/손실:
$-32.94M
주가수익비율:
-5.2523
EPS:
-1.11
순현금흐름:
$-24.95M
1주 성능:
+4.86%
1개월 성능:
+33.11%
6개월 성능:
+116.73%
1년 성능:
+89.90%
1일 변동 폭
$5.5101
$6.025
1주일 범위
$5.30
$6.025
52주 변동 폭
$1.84
$6.025
Achieve Life Sciences Inc Stock (ACHV) Company Profile
명칭
Achieve Life Sciences Inc
전화
425-686-1500
주소
22722 29TH DR. SE, SEATTLE, BC
ACHV을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
5.83 | 297.58M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-25 | 개시 | Citizens JMP | Mkt Outperform |
| 2025-08-21 | 개시 | H.C. Wainwright | Buy |
| 2024-11-14 | 개시 | Rodman & Renshaw | Buy |
| 2024-09-27 | 개시 | Raymond James | Strong Buy |
| 2023-05-10 | 재확인 | Maxim Group | Buy |
| 2021-06-23 | 개시 | Oppenheimer | Outperform |
모두보기
Achieve Life Sciences Inc 주식(ACHV)의 최신 뉴스
Quarterly Earnings: Is Achieve Life Sciences Inc forming a breakout patternShort Setup & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Is Expected To Breakeven In The Near Future - Yahoo Finance
Whats the fair value of Achieve Life Sciences Inc stockAnalyst Downgrade & Low Risk Investment Opportunities - baoquankhu1.vn
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
Achieve Life Sciences’ smoking treatment likely to be approved by FDA, says Hunterbrook - MSN
Achieve Life Sciences appoints Mark Rubinstein as permanent CMO By Investing.com - Investing.com Nigeria
Achieve Life Sciences (ACHV) Appoints New Chief Medical Officer - GuruFocus
Achieve Life Sciences appoints Mark Rubinstein as permanent CMO - Investing.com
Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer - The Manila Times
Achieve Life Sciences Confirms Mark Rubinstein as Chief Medical Officer - Quiver Quantitative
Achieve Life Sciences, Inc. Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer - marketscreener.com
Can Achieve Life Sciences Inc. stock continue upward trendPortfolio Gains Report & AI Enhanced Trading Alerts - Улправда
Why Achieve Life Sciences Inc. stock is recommended by analystsJuly 2025 Market Mood & Weekly Top Stock Performers List - Улправда
Will Achieve Life Sciences Inc. stock benefit from automation2025 Bull vs Bear & Proven Capital Preservation Methods - Улправда
Can Achieve Life Sciences Inc. stock resist sector downturns2025 Trading Volume Trends & Long-Term Capital Growth Strategies - Улправда
Is Achieve Life Sciences Inc. stock undervalued vs historical averages2025 Bull vs Bear & Expert Curated Trade Setups - ulpravda.ru
How supply chain issues affect Achieve Life Sciences Inc. stockGlobal Markets & Momentum Based Trading Ideas - ulpravda.ru
Will Achieve Life Sciences Inc. stock outperform value stocks2025 Geopolitical Influence & High Win Rate Trade Tips - Улправда
Will Achieve Life Sciences Inc. stock deliver strong dividend growth2025 Sector Review & Smart Swing Trading Alerts - Улправда
Achieve Life Sciences, Inc.Common Shares (NQ: ACHV - FinancialContent
Achieve Life Sciences gets new interim chief medical officer - MSN
11 creative campaigns to know about today - Ad Age
Will Achieve Life Sciences Inc. (SP4P) stock rise with strong economyStock Price Divergence & Free Grow Wealth With Picks - Улправда
What analysts say about Achieve Life Sciences Inc stockLow Risk Investment Ideas & Rapid Portfolio Investment - earlytimes.in
Aug Wrap: Can Achieve Life Sciences Inc. stock continue upward trendMarket Trend Review & Free Accurate Trade Setup Notifications - moha.gov.vn
Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above 200-Day Moving AverageHere's Why - MarketBeat
How risky is Achieve Life Sciences Inc. (SP4P) stock compared to peers2026 world cup usa national team round of 16 midfield engines transition play match prediction analysis - Улправда
Achieve Life Sciences jumps on Hunterbrook Capital endorsement - MSN
Achieve Life Sciences (ACHV) Identified as Top Biopharma Prospec - GuruFocus
Options Flow: Will Achieve Life Sciences Inc stock outperform value stocksDividend Hike & Step-by-Step Swing Trade Plans - moha.gov.vn
When Will Achieve Life Sciences, Inc. (NASDAQ:ACHV) Become Profitable? - simplywall.st
Achieve Life Sciences: Market Watchdogs Eager - StocksToTrade
Achieve Life Sciences’ Smoking Treatment Likely To Be Approved By FDA, Says Hunterbrook - Stocktwits
Achieve Life Sciences (ACHV) Gains on Promising Cytisinicline An - GuruFocus
New Report Calls Achieve Life's Cytisinicline Best Therapy To Quit Smoking - Sahm
Achieve Life Sciences (ACHV) Nears FDA Approval for Anti-Smoking Drug - GuruFocus
Achieve Life Sciences shares rise as Hunterbrook Capital takes bullish position - Investing.com Canada
Achieve Life Sciences (NASDAQ:ACHV) Shares Cross Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Achieve Life Sciences (NASDAQ:ACHV) Shares Cross Above Two Hundred Day Moving Average – Here’s Why - Defense World
ACHV (Achieve Life Sciences) EV-to-OCF : -4.70 (As of Dec. 21, 2025) - GuruFocus
Published on: 2025-12-21 13:53:54 - Улправда
How Achieve Life Sciences Inc. (SP4P) stock performs during market turbulenceJuly 2025 Reactions & Smart Allocation Stock Tips - Улправда
CEO Moves: Can Achieve Life Sciences Inc. stock continue upward trend2025 Valuation Update & Weekly Watchlist for Consistent Profits - ulpravda.ru
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Achieve Life Sciences (NASDAQ:ACHV) Stock Price Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Market Fear: Why Achieve Life Sciences Inc. stock is a value investor pickMarket Performance Recap & Low Drawdown Momentum Trade Ideas - moha.gov.vn
How Achieve Life Sciences Inc. stock performs in weak economyForecast Cut & AI Optimized Trading Strategy Guides - Улправда
Achieve Life Sciences (FRA:SP4P) EV-to-OCF : -4.51 (As of Dec. 19, 2025) - GuruFocus
How Achieve Life Sciences Inc. stock compares to industry benchmarksJuly 2025 Chart Watch & Accurate Entry/Exit Alerts - DonanımHaber
Achieve Life Sciences Inc (ACHV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Achieve Life Sciences Inc 주식 (ACHV) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Oki Mark K | Chief Financial Officer |
Sep 18 '25 |
Sale |
2.92 |
50,060 |
146,175 |
127,940 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Option Exercise |
0.00 |
297,500 |
0 |
358,376 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Sale |
2.92 |
129,501 |
378,143 |
228,875 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
34,100 |
0 |
46,764 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Sale |
2.77 |
14,070 |
38,974 |
32,694 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Option Exercise |
0.00 |
455,000 |
0 |
455,000 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Sale |
2.77 |
139,858 |
387,407 |
315,142 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Option Exercise |
0.00 |
110,000 |
0 |
143,214 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Sale |
2.77 |
27,629 |
76,532 |
115,585 |
| Xinos Jaime | Chief Commercial Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
69,000 |
0 |
95,286 |
4.73%
0.92%
자본화:
|
볼륨(24시간):